Barbara Burwinkel

researcher

Barbara Burwinkel is …
instance of (P31):
humanQ5

P734family nameBurwinkelQ37489243
BurwinkelQ37489243
BurwinkelQ37489243
P101field of workmetabolomicsQ12149006
P735given nameBarbaraQ153957
BarbaraQ153957
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q3601638611q13 is a susceptibility locus for hormone receptor positive breast cancer
Q3587156719p13.1 is a triple-negative-specific breast cancer susceptibility locus
Q5683608440 EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004
Q360214067q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium
Q371698739q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium
Q51569689A BRCA1 promoter variant (rs11655505) and breast cancer risk.
Q46462920A bias in genotyping the ERBB2 (HER2) Ile655Val variant
Q37313778A breast cancer risk haplotype in the caspase-8 gene
Q84920409A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk
Q37332232A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk
Q37619303A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium
Q33368134A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults
Q92711687A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
Q92152049A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival
Q53651538A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.
Q57305942A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer
Q53315710A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women.
Q52605797A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk.
Q28237116ARLTS1 variants and melanoma risk
Q57192440ARLTS1 variants and risk of colorectal cancer
Q39437211Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers
Q33279172Allelotyping of pooled DNA with 250 K SNP microarrays
Q52937376Arthrogryposis multiplex with deafness, inguinal hernias, and early death: a family report of a probably autosomal recessive trait.
Q56987646Association Between Functional FABP2 Promoter Haplotype and Type 2 Diabetes
Q45979098Association analysis identifies 65 new breast cancer risk loci.
Q94355861Association of () polymorphisms with breast cancer risk
Q37292963Association of ESR1 gene tagging SNPs with breast cancer risk
Q46402532Association of NCOA3 polymorphisms with breast cancer risk
Q46707380Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis
Q44471824Association of acyl-CoA-binding protein (ACBP) single nucleotide polymorphisms and type 2 diabetes in two German study populations
Q37684672Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.
Q54657396Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk.
Q37268494Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
Q51836207Association of genetic variants in the Rho guanine nucleotide exchange factor AKAP13 with familial breast cancer.
Q54620954Association of prolactin and its receptor gene regions with familial breast cancer.
Q53651814Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant.
Q35532898Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium
Q28240593Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer
Q57056093Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
Q37002955BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
Q33284720BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study
Q46115524Body mass index and breast cancer survival: a Mendelian randomization analysis
Q100457582Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk
Q34327945Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2
Q35940158Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
Q39465495CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer
Q36449203CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer
Q36419325CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer
Q42917130Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures
Q28385765Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk
Q28655235Capture and Amplification by Tailing and Switching (CATS). An ultrasensitive ligation-independent method for generation of DNA libraries for deep sequencing from picogram amounts of DNA and RNA
Q52730409Cell-free DNA in breast cancer: a long way to go.
Q40074752Cell-free circulating DNA Integrity based on peripheral blood as a biomarker for diagnosis of cancer: a systematic review
Q40043175Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence
Q24603537Characterization of extracellular circulating microRNA
Q40571462Check and mate to exosomal extracellular miRNA: new lesson from a new approach
Q48230033Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer
Q34297783Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer
Q40965602Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis
Q54294896Circulating microRNAs in plasma as early detection markers for breast cancer.
Q37368000Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms
Q35794653Common germline polymorphisms associated with breast cancer-specific survival
Q34379032Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
Q31082788Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q36026731Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer
Q34181322Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer
Q34002454Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk
Q36403891Copy number variation in patients with cervical artery dissection
Q57278898Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q57191514DNA methylation array analyses identified breast cancer-associatedHYAL2methylation in peripheral blood
Q37665624DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.
Q51780977Death receptor 4 variants and colorectal cancer risk.
Q36552828Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma
Q55007492Evaluation of Promoter Methylation of RASSF1A and ATM in Peripheral Blood of Breast Cancer Patients and Healthy Control Individuals.
Q35009015Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases
Q35653910Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk
Q35064451Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
Q37342144Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation
Q39124540Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts
Q30245610Extracellular miRNA: A Collision of Two Paradigms
Q44235487Extracellular miRNAs: the mystery of their origin and function
Q35052285F2RL3 methylation as a biomarker of current and lifetime smoking exposures
Q34649151F2RL3 methylation in blood DNA is a strong predictor of mortality
Q44021766F2RL3 methylation, lung cancer incidence and mortality
Q35999309FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor
Q37594336FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium
Q43165954FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer
Q24301469Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency
Q37236216Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).
Q36111237Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus
Q35524465Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
Q61230414Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes
Q92480972Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Q35063160Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk
Q39844032Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer
Q36248936Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk
Q34903062Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
Q37367871Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
Q34794063First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome
Q37002930Five endometrial cancer risk loci identified through genome-wide association analysis
Q34979715Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium
Q53585636Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study.
Q36124728Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
Q36742577Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers
Q37389405Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer
Q40545184Genetic Variants in the Vitamin D Pathway, 25(OH)D Levels, and Mortality in a Large Population-Based Cohort Study
Q37739048Genetic modifiers of CHEK2*1100delC-associated breast cancer risk
Q54940815Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses.
Q35925620Genetic predisposition to ductal carcinoma in situ of the breast
Q35151684Genetic predisposition to in situ and invasive lobular carcinoma of the breast
Q36070191Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer
Q100426886Genetic variants in the regulatory T cell related pathway and colorectal cancer prognosis
Q53291654Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk.
Q35179897Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
Q34378972Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade
Q36422109Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium
Q44752870Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk
Q44202581Genetic variations in the vitamin D binding protein and season-specific levels of vitamin D among older adults
Q30000080Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent
Q28388497Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
Q50174463Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier).
Q92737473Genome-wide DNA methylation differences according to oestrogen receptor beta status in colorectal cancer
Q45087021Genome-wide analysis associates familial colorectal cancer with increases in copy number variations and a rare structural variation at 12p12.3.
Q36842233Genome-wide association analysis identifies three new breast cancer susceptibility loci
Q35996692Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Q63681757Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
Q24622610Genome-wide association studies identify four ER negative-specific breast cancer risk loci
Q54664157Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility.
Q95329367Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
Q64040390Genome-wide association study of germline variants and breast cancer-specific mortality
Q34094502Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease
Q96432094Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
Q53163641Germline variants of base excision repair genes and breast cancer: A polymorphism in DNA polymerase gamma modifies gene expression and breast cancer risk.
Q41840249HYAL2 methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control study
Q36276540Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization
Q35102646Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk
Q34729935Identification and evaluation of plasma microRNAs for early detection of colorectal cancer
Q36720814Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk
Q44028747Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity
Q36859142Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
Q43223092Identification of frequent chromosome copy-number polymorphisms by use of high-resolution single-nucleotide-polymorphism arrays
Q36086247Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus
Q46627824Identification of new acyl-CoA binding protein transcripts in human and mouse
Q57170142Identification of nine new susceptibility loci for endometrial cancer
Q36014067Identification of novel genetic markers of breast cancer survival
Q46103372Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Q114184688Incorporating progesterone receptor expression into the PREDICT breast prognostic model
Q35104068Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer
Q43506703Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer
Q38315168Isolation of circulating microRNA associated with RNA-binding protein
Q57191573Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair
Q28267893Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair
Q29416989Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Q35119701Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium
Q43255116Low-risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients
Q46711428MTHFR genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia
Q114182490Mendelian randomisation study of smoking exposure in relation to breast cancer risk
Q36333368Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.
Q40201374Metabolic shifts in residual breast cancer drive tumor recurrence
Q41239086Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy
Q34497352MicroRNA related polymorphisms and breast cancer risk
Q37873226MicroRNA signatures: novel biomarker for colorectal cancer?
Q34123806Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls
Q45174307Molecular and clinical characterization of an in frame deletion of uncertain clinical significance in the BRCA2 gene
Q53553688Molecular genetic analysis of NBS1 in German melanoma patients.
Q46943095Multicentre study of CASP8 polymorphisms in breast cancer
Q36897003Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Q28181983Muscle glycogenosis with low phosphorylase kinase activity: mutations in PHKA1, PHKG1 or six other candidate genes explain only a minority of cases
Q24601453Mutations in ROGDI Cause Kohlschütter-Tönz Syndrome
Q37356243Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.
Q38597275No Association of Vitamin D Pathway Genetic Variants with Cancer Risks in a Population-Based Cohort of German Older Adults
Q30374367No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Q37079859No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing
Q33583309Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
Q28584533PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Q47143943PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.
Q34085823Pancreatic cancer susceptibility loci and their role in survival
Q56089175Pathway analysis of genetic variants in folate-mediated one-carbon metabolism-related genes and survival in a prospectively followed cohort of colorectal cancer patients
Q38993983Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis
Q40768670Plasma S100P level as a novel prognostic marker of metastatic breast cancer
Q41035419Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer
Q40579865Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer
Q35032320Plasma microRNA panel for minimally invasive detection of breast cancer
Q62583133Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Q48296505Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk
Q36066735Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression
Q43613530Polymorphisms in genes involved in GH1 release and their association with breast cancer risk
Q80636308Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer
Q36583004Prediction of breast cancer risk based on profiling with common genetic variants
Q56987671Preliminary Evidence of FABP2 A54T Polymorphism Associated with Reduced Risk of Type 2 Diabetes and Obesity in Women from a German Cohort
Q55508030Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Q90242034Publisher Correction: Shared heritability and functional enrichment across six solid cancers
Q36009422RAD51B in Familial Breast Cancer
Q46585200Re: Association of a common variant of the CASP8 gene with reduced risk of breast cancer
Q35155449Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia
Q38913971Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancer
Q37300024Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
Q41641041S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancer
Q34369604SNP genotyping on a genome-wide amplified DOP-PCR template
Q36545934SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival
Q40936032SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patients
Q80442969SNPs in ultraconserved elements and familial breast cancer risk
Q34485182Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients
Q34224330Severe phenotype of phosphorylase kinase-deficient liver glycogenosis with mutations in the PHKG2 gene
Q61118451Shared heritability and functional enrichment across six solid cancers
Q64004349Shared heritability and functional enrichment across six solid cancers
Q34236472Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease
Q24810703TP53-binding protein variants and breast cancer risk: a case-control study
Q33535259Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells
Q57319812Ten recently identified associations between nsSNPs and colorectal cancer could not be replicated in German families
Q49817640The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.
Q33300099The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study
Q91178389The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Q40234422The association between breast cancer and S100P methylation in peripheral blood by multicenter case-control studies
Q61443921The associations of DNA methylation alterations in oxidative stress-related genes with cancer incidence and mortality outcomes: a population-based cohort study
Q57192415The functional genetic variant Arg324Gly of frizzled-related protein is associated with colorectal cancer risk
Q38309964The functional genetic variant Ile646Val located in the kinase binding domain of the A-kinase anchoring protein 10 is associated with familial breast cancer
Q45154642The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk
Q47163164The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk.
Q36142060The role of genetic breast cancer susceptibility variants as prognostic factors
Q57265670The rs12975333 variant in the miR-125a and breast cancer risk in Germany, Italy, Australia and Spain
Q53639998The single nucleotide polymorphism IVS1+309 in mouse double minute 2 does not affect risk of familial breast cancer.
Q33860650Tobacco-smoking-related differential DNA methylation: 27K discovery and replication
Q33263818Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study
Q89961489Transcriptome-wide association study of breast cancer risk by estrogen-receptor status
Q92994868Two truncating variants in FANCC and breast cancer risk
Q39489381Vitamin D receptor genotype rs731236 (Taq1) and breast cancer prognosis
Q53088630Vitamin D receptor polymorphism and colorectal cancer-specific and all-cause mortality.
Q46521646c-MYC Asn11Ser is associated with increased risk for familial breast cancer
Q45957040miR-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in irritable bowel syndrome.
Q37414133rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk

Search more.